about
A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Androgen receptor genomic regulation.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ETS rearrangements in prostate cancer
@en
ETS rearrangements in prostate cancer.
@nl
type
label
ETS rearrangements in prostate cancer
@en
ETS rearrangements in prostate cancer.
@nl
prefLabel
ETS rearrangements in prostate cancer
@en
ETS rearrangements in prostate cancer.
@nl
P2860
P356
P1476
ETS rearrangements in prostate cancer
@en
P2860
P304
P356
10.1038/AJA.2011.145
P50
P577
2012-04-16T00:00:00Z